Clinical Trials Browser

Phase 1/2 × OTHER × Extensive Stage Small Cell Lung Cancer × Clear all

NCT06597513 2024-10-15

Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC

Phase 1/2 Not yet recruiting

Extensive Stage Small Cell Lung Cancer